array(40) {
  [0]=>
  string(4) "9252"
  ["article_id"]=>
  string(4) "9252"
  [1]=>
  string(74) "It's time FDA and CISA update their medical device agreement, says GAO"
  ["article_title"]=>
  string(74) "It's time FDA and CISA update their medical device agreement, says GAO"
  [2]=>
  string(158) "The watchdog agency said that it found the existing coordination agreement does not reflect "organizational and procedural changes," including the FDA"
  ["short_description"]=>
  string(158) "The watchdog agency said that it found the existing coordination agreement does not reflect "organizational and procedural changes," including the FDA"
  [3]=>
  string(239) "The watchdog agency said that it found the existing coordination agreement does not reflect "organizational and procedural changes," including the FDA's authority to find that medical devices in use violate federal law. &#nl"
  ["description"]=>
  string(239) "The watchdog agency said that it found the existing coordination agreement does not reflect "organizational and procedural changes," including the FDA's authority to find that medical devices in use violate federal law. &#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(106) "https://www.healthcareitnews.com/news/its-time-fda-and-cisa-update-their-medical-device-agreement-says-gao"
  ["blog_url"]=>
  string(106) "https://www.healthcareitnews.com/news/its-time-fda-and-cisa-update-their-medical-device-agreement-says-gao"
  [15]=>
  string(19) "2023-12-28 23:01:40"
  ["add_date"]=>
  string(19) "2023-12-28 23:01:40"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9253"
  ["article_id"]=>
  string(4) "9253"
  [1]=>
  string(64) "NewYork-Presbyterian pays $300K to settle NY pixel tracking case"
  ["article_title"]=>
  string(64) "NewYork-Presbyterian pays $300K to settle NY pixel tracking case"
  [2]=>
  string(163) "The hospital "failed to handle its patients’ health information with care," said Attorney General Letitia James. It has pledged to update its polici"
  ["short_description"]=>
  string(163) "The hospital "failed to handle its patients’ health information with care," said Attorney General Letitia James. It has pledged to update its polici"
  [3]=>
  string(272) "The hospital "failed to handle its patients’ health information with care," said Attorney General Letitia James. It has pledged to update its policies on third-party tools, ensure deletion of PHI gathered by those tools and boost its privacy safeguards.&#nl"
  ["description"]=>
  string(272) "The hospital "failed to handle its patients’ health information with care," said Attorney General Letitia James. It has pledged to update its policies on third-party tools, ensure deletion of PHI gathered by those tools and boost its privacy safeguards.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(98) "https://www.healthcareitnews.com/news/newyork-presbyterian-pays-300k-settle-ny-pixel-tracking-case"
  ["blog_url"]=>
  string(98) "https://www.healthcareitnews.com/news/newyork-presbyterian-pays-300k-settle-ny-pixel-tracking-case"
  [15]=>
  string(19) "2023-12-28 21:00:00"
  ["add_date"]=>
  string(19) "2023-12-28 21:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9254"
  ["article_id"]=>
  string(4) "9254"
  [1]=>
  string(81) "JAMA research: AI model explanations don't meaningfully mitigate against bias"
  ["article_title"]=>
  string(81) "JAMA research: AI model explanations don't meaningfully mitigate against bias"
  [2]=>
  string(150) "A randomized clinical vignette survey across more than a dozen states, with hospitalists, NPs and PAs taking part, evaluated systematically biased alg"
  ["short_description"]=>
  string(150) "A randomized clinical vignette survey across more than a dozen states, with hospitalists, NPs and PAs taking part, evaluated systematically biased alg"
  [3]=>
  string(223) "A randomized clinical vignette survey across more than a dozen states, with hospitalists, NPs and PAs taking part, evaluated systematically biased algorithms and how clinicians make decisions with image-based AI guides.&#nl"
  ["description"]=>
  string(223) "A randomized clinical vignette survey across more than a dozen states, with hospitalists, NPs and PAs taking part, evaluated systematically biased algorithms and how clinicians make decisions with image-based AI guides.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(113) "https://www.healthcareitnews.com/news/jama-research-ai-model-explanations-dont-meaningfully-mitigate-against-bias"
  ["blog_url"]=>
  string(113) "https://www.healthcareitnews.com/news/jama-research-ai-model-explanations-dont-meaningfully-mitigate-against-bias"
  [15]=>
  string(19) "2023-12-27 23:10:21"
  ["add_date"]=>
  string(19) "2023-12-27 23:10:21"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9255"
  ["article_id"]=>
  string(4) "9255"
  [1]=>
  string(66) "Successful RPM needs leading edge tech, thoughtful implementations"
  ["article_title"]=>
  string(66) "Successful RPM needs leading edge tech, thoughtful implementations"
  [2]=>
  string(150) "Done right, more widespread adoption of remote patient monitoring will offer breakthrough innovations where healthcare delivery can be improved, clini"
  ["short_description"]=>
  string(150) "Done right, more widespread adoption of remote patient monitoring will offer breakthrough innovations where healthcare delivery can be improved, clini"
  [3]=>
  string(248) "Done right, more widespread adoption of remote patient monitoring will offer breakthrough innovations where healthcare delivery can be improved, clinician workloads can be right-sized and better patient outcomes can be achieved, an expert says.&#nl"
  ["description"]=>
  string(248) "Done right, more widespread adoption of remote patient monitoring will offer breakthrough innovations where healthcare delivery can be improved, clinician workloads can be right-sized and better patient outcomes can be achieved, an expert says.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(103) "https://www.healthcareitnews.com/news/successful-rpm-needs-leading-edge-tech-thoughtful-implementations"
  ["blog_url"]=>
  string(103) "https://www.healthcareitnews.com/news/successful-rpm-needs-leading-edge-tech-thoughtful-implementations"
  [15]=>
  string(19) "2023-12-27 22:58:41"
  ["add_date"]=>
  string(19) "2023-12-27 22:58:41"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9045"
  ["article_id"]=>
  string(4) "9045"
  [1]=>
  string(82) "FDA Requires Updates to Labeling for Promethazine Hydrochloride Injection Products"
  ["article_title"]=>
  string(82) "FDA Requires Updates to Labeling for Promethazine Hydrochloride Injection Products"
  [2]=>
  string(150) "Audience: Health Care Professionals December 27, 2023 -- FDA is alerting health care professionals of labeling updates intended to further reduce the "
  ["short_description"]=>
  string(150) "Audience: Health Care Professionals December 27, 2023 -- FDA is alerting health care professionals of labeling updates intended to further reduce the "
  [3]=>
  string(244) "Audience: Health Care Professionals December 27, 2023 -- FDA is alerting health care professionals of labeling updates intended to further reduce the risk of severe chemical irritation and damage to tissues from intravenous administration of..."
  ["description"]=>
  string(244) "Audience: Health Care Professionals December 27, 2023 -- FDA is alerting health care professionals of labeling updates intended to further reduce the risk of severe chemical irritation and damage to tissues from intravenous administration of..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "7"
  ["rss_id"]=>
  string(1) "7"
  [14]=>
  string(102) "https://www.drugs.com/fda/fda-requires-updates-labeling-promethazine-hydrochloride-products-14643.html"
  ["blog_url"]=>
  string(102) "https://www.drugs.com/fda/fda-requires-updates-labeling-promethazine-hydrochloride-products-14643.html"
  [15]=>
  string(19) "2023-12-27 20:12:00"
  ["add_date"]=>
  string(19) "2023-12-27 20:12:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:47"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:47"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9256"
  ["article_id"]=>
  string(4) "9256"
  [1]=>
  string(59) "St Vincent's Health reports data heist before Christmas"
  ["article_title"]=>
  string(59) "St Vincent's Health reports data heist before Christmas"
  [2]=>
  string(140) "Australia's largest not-for-profit health and aged care provider is still figuring out which data were "removed" by hackers.&#nl"
  ["short_description"]=>
  string(140) "Australia's largest not-for-profit health and aged care provider is still figuring out which data were "removed" by hackers.&#nl"
  [3]=>
  string(140) "Australia's largest not-for-profit health and aged care provider is still figuring out which data were "removed" by hackers.&#nl"
  ["description"]=>
  string(140) "Australia's largest not-for-profit health and aged care provider is still figuring out which data were "removed" by hackers.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(89) "https://www.healthcareitnews.com/news/anz/st-vincents-health-reports-data-heist-christmas"
  ["blog_url"]=>
  string(89) "https://www.healthcareitnews.com/news/anz/st-vincents-health-reports-data-heist-christmas"
  [15]=>
  string(19) "2023-12-27 16:07:09"
  ["add_date"]=>
  string(19) "2023-12-27 16:07:09"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9257"
  ["article_id"]=>
  string(4) "9257"
  [1]=>
  string(64) "What's in Australia's 10-year digital health blueprint? "
  ["article_title"]=>
  string(64) "What's in Australia's 10-year digital health blueprint? "
  [2]=>
  string(109) "It is doubling down on data access to enable personalised care and connected health over the next decade.&#nl"
  ["short_description"]=>
  string(109) "It is doubling down on data access to enable personalised care and connected health over the next decade.&#nl"
  [3]=>
  string(109) "It is doubling down on data access to enable personalised care and connected health over the next decade.&#nl"
  ["description"]=>
  string(109) "It is doubling down on data access to enable personalised care and connected health over the next decade.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(91) "https://www.healthcareitnews.com/news/anz/whats-australias-10-year-digital-health-blueprint"
  ["blog_url"]=>
  string(91) "https://www.healthcareitnews.com/news/anz/whats-australias-10-year-digital-health-blueprint"
  [15]=>
  string(19) "2023-12-27 16:04:16"
  ["add_date"]=>
  string(19) "2023-12-27 16:04:16"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9071"
  ["article_id"]=>
  string(4) "9071"
  [1]=>
  string(66) "Amgen Provides Regulatory Update on Status of Lumakras (sotorasib)"
  ["article_title"]=>
  string(66) "Amgen Provides Regulatory Update on Status of Lumakras (sotorasib)"
  [2]=>
  string(150) "THOUSAND OAKS, Calif., Dec. 26, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) announced today that the U.S. Food and Drug Administration (FDA) has complete"
  ["short_description"]=>
  string(150) "THOUSAND OAKS, Calif., Dec. 26, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) announced today that the U.S. Food and Drug Administration (FDA) has complete"
  [3]=>
  string(245) "THOUSAND OAKS, Calif., Dec. 26, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) announced today that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of..."
  ["description"]=>
  string(245) "THOUSAND OAKS, Calif., Dec. 26, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) announced today that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "9"
  ["rss_id"]=>
  string(1) "9"
  [14]=>
  string(46) "https://www.drugs.com/nda/lumakras_231226.html"
  ["blog_url"]=>
  string(46) "https://www.drugs.com/nda/lumakras_231226.html"
  [15]=>
  string(19) "2023-12-27 07:12:28"
  ["add_date"]=>
  string(19) "2023-12-27 07:12:28"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:48"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:48"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9258"
  ["article_id"]=>
  string(4) "9258"
  [1]=>
  string(80) "FirstHealth of the Carolinas solves access problem with Virtual Provider program"
  ["article_title"]=>
  string(80) "FirstHealth of the Carolinas solves access problem with Virtual Provider program"
  [2]=>
  string(152) "With telemedicine, the time for patients coming out of the ER or a convenience clinic to see a primary care provider has gone from weeks to 24-72 hou"
  ["short_description"]=>
  string(152) "With telemedicine, the time for patients coming out of the ER or a convenience clinic to see a primary care provider has gone from weeks to 24-72 hou"
  [3]=>
  string(271) "With telemedicine, the time for patients coming out of the ER or a convenience clinic to see a primary care provider has gone from weeks to 24-72 hours. And virtual care has helped the health system achieve a 72% completion rate of Medicare annual wellness visits.&#nl"
  ["description"]=>
  string(271) "With telemedicine, the time for patients coming out of the ER or a convenience clinic to see a primary care provider has gone from weeks to 24-72 hours. And virtual care has helped the health system achieve a 72% completion rate of Medicare annual wellness visits.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(106) "https://www.healthcareitnews.com/news/firsthealth-carolinas-solves-access-problem-virtual-provider-program"
  ["blog_url"]=>
  string(106) "https://www.healthcareitnews.com/news/firsthealth-carolinas-solves-access-problem-virtual-provider-program"
  [15]=>
  string(19) "2023-12-27 00:13:34"
  ["add_date"]=>
  string(19) "2023-12-27 00:13:34"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9072"
  ["article_id"]=>
  string(4) "9072"
  [1]=>
  string(135) "Milestone Pharmaceuticals Receives Refusal to File Letter from U.S. FDA for New Drug Application for Etripamil in the Treatment of PSVT"
  ["article_title"]=>
  string(135) "Milestone Pharmaceuticals Receives Refusal to File Letter from U.S. FDA for New Drug Application for Etripamil in the Treatment of PSVT"
  [2]=>
  string(150) "MONTREAL and CHARLOTTE, N.C., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) announced today that the Company receive"
  ["short_description"]=>
  string(150) "MONTREAL and CHARLOTTE, N.C., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) announced today that the Company receive"
  [3]=>
  string(251) "MONTREAL and CHARLOTTE, N.C., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) announced today that the Company received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for the New Drug..."
  ["description"]=>
  string(251) "MONTREAL and CHARLOTTE, N.C., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) announced today that the Company received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for the New Drug..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "9"
  ["rss_id"]=>
  string(1) "9"
  [14]=>
  string(47) "https://www.drugs.com/nda/cardamyst_231226.html"
  ["blog_url"]=>
  string(47) "https://www.drugs.com/nda/cardamyst_231226.html"
  [15]=>
  string(19) "2023-12-26 08:12:02"
  ["add_date"]=>
  string(19) "2023-12-26 08:12:02"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:48"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:48"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9111"
  ["article_id"]=>
  string(4) "9111"
  [1]=>
  string(77) "First patient dosed in Phase III prostate cancer trial with Cu-64 SAR-bisPSMA"
  ["article_title"]=>
  string(77) "First patient dosed in Phase III prostate cancer trial with Cu-64 SAR-bisPSMA"
  [2]=>
  string(158) "SYDNEY, Dec. 22, 2023. Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-gen"
  ["short_description"]=>
  string(158) "SYDNEY, Dec. 22, 2023. Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-gen"
  [3]=>
  string(260) "SYDNEY, Dec. 22, 2023. Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to..."
  ["description"]=>
  string(260) "SYDNEY, Dec. 22, 2023. Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(118) "https://www.drugs.com/clinical_trials/first-patient-dosed-phase-iii-prostate-cancer-trial-cu-64-sar-bispsma-21241.html"
  ["blog_url"]=>
  string(118) "https://www.drugs.com/clinical_trials/first-patient-dosed-phase-iii-prostate-cancer-trial-cu-64-sar-bispsma-21241.html"
  [15]=>
  string(19) "2023-12-23 05:12:07"
  ["add_date"]=>
  string(19) "2023-12-23 05:12:07"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:50"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9046"
  ["article_id"]=>
  string(4) "9046"
  [1]=>
  string(147) "Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene"
  ["article_title"]=>
  string(147) "Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene"
  [2]=>
  string(150) "Audience: Consumer, Health Professional, Pharmacy TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Heal"
  ["short_description"]=>
  string(150) "Audience: Consumer, Health Professional, Pharmacy TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Heal"
  [3]=>
  string(249) "Audience: Consumer, Health Professional, Pharmacy TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling one lot of Americaine®..."
  ["description"]=>
  string(249) "Audience: Consumer, Health Professional, Pharmacy TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling one lot of Americaine®..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "7"
  ["rss_id"]=>
  string(1) "7"
  [14]=>
  string(128) "https://www.drugs.com/fda/insight-pharmaceuticals-issues-voluntary-nationwide-recall-americaine-20-benzocaine-topical-14645.html"
  ["blog_url"]=>
  string(128) "https://www.drugs.com/fda/insight-pharmaceuticals-issues-voluntary-nationwide-recall-americaine-20-benzocaine-topical-14645.html"
  [15]=>
  string(19) "2023-12-22 20:39:00"
  ["add_date"]=>
  string(19) "2023-12-22 20:39:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:47"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:47"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}